MRSi 2023: Lucky 21 Celebrating Victories in IVF
David Sable, MD
David Sable MD directs healthcare and life science investing, both public and venture, for AWM InvestmentCompany in New York. After graduating from the Wharton School and the University of Pennsylvania School of Medicine, he trained in obstetrics and gynecology at New York Hospital - Cornell, and in reproductive endocrinology at the Brigham and Women's Hospital. He co-founded and served as director of the Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center in New Jersey, was founder of Assisted Reproductive Medical Technologies, which was acquired by Saint Barnabas in 1999, and cofounder of Reprogenetics, acquired by Cooper Surgical in 2015. Dr. Sable is an adjunct in the department of biology at Columbia University, and teaches “Entrepreneurship in Biotechnology” at Columbia’s Graduate School of Arts and Sciences. He has served as a board member for Genenews Inc, Hamilton Thorne Ltd, Ohana BioSciences, Celmatix, MedAnswers and TMRW Life Sciences and for the nonprofit advocacy organization RESOLVE, and on the medical and scientific advisory boards of Ovascience and Progyny. In addition to his academic publications, he has written for the Newark Star-Ledger, Yoga Journal, Xconomy, Genetic Engineering and Biotechnology News, Wharton Magazine, and Forbes, covering the biotechnology and reproductive medicine industries.
Sessions
Keynote - Access To Care In IVF, How Science Politics and Venture Capital Go Together; The Time Is Now! CME/CE
Thursday, June 8, 2023
9:00am - 10:00am
Moving A Company To IPO
Thursday, June 8, 2023
4:15pm - 5:00pm